Latest News and Press Releases
Want to stay updated on the latest news?
-
Newark, Sept. 03, 2024 (GLOBE NEWSWIRE) -- According to The Brainy Insights, the ophthalmic drugs market is characterized by a variety of pharmaceutical products used to treat eye conditions,...
-
Newark, Sept. 25, 2023 (GLOBE NEWSWIRE) -- The Brainy Insights estimates that the USD 35 billion in 2022 global ophthalmic drugs market will reach USD 62.67 billion in 2032. The number of people...
-
Ottawa, Aug. 16, 2023 (GLOBE NEWSWIRE) -- The global ophthalmic drugs market was valued at USD 39.28 billion in 2022. The North American region has dominated the market with revenue share 40% in the...
-
Rockville, June 28, 2023 (GLOBE NEWSWIRE) -- As per Fact.MR, a provider of market research and competitive intelligence, Ophthalmic Drugs Market is predicted to grow at a CAGR of 6.6% and the market...
-
Burlingame, June 15, 2023 (GLOBE NEWSWIRE) -- According to Coherent Market Insights, global Ophthalmic Drugs market is estimated to be valued at US$ 45.62 Billion in 2022 and is expected to exhibit...
-
Covina, May 25, 2023 (GLOBE NEWSWIRE) -- “According to the latest research study, the demand of Ophthalmic Drugs Market accounted for US$ 33.81 billion in 2022 and is estimated to be US$ 78.4...
-
New York, United States , March 13, 2023 (GLOBE NEWSWIRE) -- The Global Ophthalmic Drugs Market Size to grow from USD 39.10 billion in 2021 to USD 66.22 billion by 2030, at a Compound Annual Growth...
-
Pune India, Jan. 06, 2023 (GLOBE NEWSWIRE) -- The market has been studied for the below mentioned-segmentation and regional analysis for North America, Europe, Asia, South America, and the Middle...
-
New York, USA, Nov. 22, 2022 (GLOBE NEWSWIRE) -- Ophthalmic Drugs Market Overview: According to a Comprehensive Research Report by Market Research Future (MRFR), “Ophthalmic Drugs Market...
-
Visiongain has just announced the publication of its brand-new report Global Ophthalmic Drugs Market Report Forecasts to 2030. Forecasts by Indication (Dry Eye, Glaucoma Drugs, Retinal Disorders Drugs...